NOVOLIMUS
Dead / Cancelled — Cancelled — Section 8 (as of 26 Jan 2024)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86415898
- Registration number
- 5241856
- Mark type
- Stylized text
- Filed
- 06 Oct 2014
- Published for opposition
- 10 Mar 2015
- Registered
- 11 Jul 2017
- Attorney of record
- Hillary I. Schroeder
Goods and services
- Class 005 — Pharmaceuticals: cardiovascular pharmaceuticals; pharmaceutical preparations for use in cardiovascular surgery; pharmaceutical preparations and substances for the treatment of inflammation and proliferation; pharmaceutical preparations for implantation and use with medical stents, catheters and stent delivery systems
- Class 010 — Medical apparatus: catheters; medical stents and stent delivery systems; and drug-eluting stents
Owner
- Elixir Medical Corporation, Milpitas, CA, US
- Elixir Medical Corporation, Milpitas, CA, US
- Elixir Medical Corporation, Sunnyvale, CA, US
Prosecution history
- 26 Jan 2024 — CANCELLED SEC. 8 (6-YR)
- 11 Jul 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 11 Jul 2017 — REGISTERED-PRINCIPAL REGISTER
- 09 Jun 2017 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 08 Jun 2017 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 07 Jun 2017 — STATEMENT OF USE PROCESSING COMPLETE
- 01 Jun 2017 — USE AMENDMENT FILED
- 01 Jun 2017 — TEAS STATEMENT OF USE RECEIVED
- 03 May 2017 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 May 2017 — SOU EXTENSION 3 GRANTED
- 01 May 2017 — SOU EXTENSION 3 FILED
- 01 May 2017 — SOU TEAS EXTENSION RECEIVED
- 15 Nov 2016 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Nov 2016 — SOU EXTENSION 2 GRANTED
- 27 Oct 2016 — SOU EXTENSION 2 FILED